{"database": "lobbying", "table": "lobbying_activities", "rows": [[3186443, "17b36376-5088-4f05-8ed9-bc351130aec6", "Q2", "RED+BLUE STRATEGIES", 400693064, "QUEST DIAGNOSTICS INCORPORATED", 2024, "second_quarter", "MMM", "Issues related to combatting the syphilis crisis in the United States and its impact on underserved communities. H.R. 4366 - Consolidated Appropriations and Other Extenders Act of 2024 - Issues related to maintaining support for laboratory programs and services for the upcoming fiscal year. H.R. 2882 - Further Consolidated Appropriations Act of 2024 - Issues related to funding of programs promulgated by the Department of Health and Human Services and its agencies, including CMS. Issues related to specific, federally-reimbursed drug testing protocols. H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2024-07-07T09:23:28-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3186443"], "units": {}, "query_ms": 38.90472499188036, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}